Dr. Jonathan Moses
Claim this profileUniversity Hospitals Cleveland Medical Center
Studies Crohn's Disease
Studies Inflammatory Bowel Disease
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Jonathan Moses is currently running
Vedolizumab
for Crohn's Disease
Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be treated with vedolizumab. The main aim of the study is to check if participants achieve remission after treatment with the vedolizumab. Remission means symptoms improve or disappear and an endoscopy shows no signs of inflammation. Participants will receive 3 infusions of vedolizumab over 6 weeks. Then, those who have a clinical response will receive either a high dose or low dose of vedolizumab once every 8 weeks. They will receive the same dose every time.
Recruiting2 awards Phase 36 criteria
Vedolizumab
for Ulcerative Colitis
Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe ulcerative colitis will be treated with vedolizumab. The main aim of the study is to check if participants achieve remission after treatment with vedolizumab. Remission means symptoms improve or disappear and an endoscopy shows no or limited signs of disease. The study is also evaluating side effects of vedolizumab in the children and teenager with moderately to severely active ulcerative colitis. Participants will receive 3 infusions of vedolizumab over 6 weeks. Then, those who have a clinical response will receive 1 of 3 doses of vedolizumab once every 8 weeks. They will receive the same dose every time.
Recruiting2 awards Phase 37 criteria
More about Jonathan Moses
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jonathan Moses has experience with
- Vedolizumab
- Methotrexate
- Sugar Pill (placebo)
- Vedolizumab IV
Breakdown of trials Jonathan Moses has run
Crohn's Disease
Inflammatory Bowel Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Moses specialize in?
Jonathan Moses focuses on Crohn's Disease and Inflammatory Bowel Disease. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Jonathan Moses currently recruiting for clinical trials?
Yes, Jonathan Moses is currently recruiting for 3 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Moses has studied deeply?
Yes, Jonathan Moses has studied treatments such as Vedolizumab, Methotrexate, Sugar pill (placebo).
What is the best way to schedule an appointment with Jonathan Moses?
Apply for one of the trials that Jonathan Moses is conducting.
What is the office address of Jonathan Moses?
The office of Jonathan Moses is located at: University Hospitals Cleveland Medical Center, Cleveland, Ohio 44106 United States. This is the address for their practice at the University Hospitals Cleveland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.